Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin's lymphoma: a probabilistic analysis.
第一作者:
A J N,Raymakers
第一单位:
Health Economics Analytic Support and Research Unit (HEASRU), BC Cancer, Vancouver, Canada. araymakers@bccrc.ca.;Canadian Centre for Applied Research in Cancer Control (ARCC), BC Cancer Research Centre, 2nd floor, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. araymakers@bccrc.ca.;Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada. araymakers@bccrc.ca.
作者:
医学主题词
费用效益分析(Cost-Benefit Analysis);女(雌)性(Female);霍奇金病(Hodgkin Disease);人类(Humans);男(雄)性(Male);概率(Probability)
DOI
10.1186/s12885-020-07374-3
PMID
33050897
发布时间
2024-03-29
- 浏览3
BMC cancer
992页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



